Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 2 Similar Profiles
Pancreatic Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Adenocarcinoma Medicine & Life Sciences
Survival Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Pancreas Medicine & Life Sciences
Radiotherapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2017

A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor

Bendell, J. C., Javle, M., Bekaii-Saab, T. S., Finn, R. S., Wainberg, Z. A., Laheru, D. A., Weekes, C. D., Tan, B. R., Khan, G. N., Zalupski, M. M., Infante, J. R., Jones, S., Papadopoulos, K. P., Tolcher, A. W., Chavira, R. E., Christy-Bittel, J. L., Barrett, E. & Patnaik, A. Feb 28 2017 In : British Journal of Cancer. 116, 5, p. 575-583 9 p.

Research output: Research - peer-reviewArticle

MEK162
Maximum Tolerated Dose
Biliary Tract Neoplasms
Neoplasms
Pharmacokinetics

BRCA2 secondary mutation-mediated resistance to platinum and PARP inhibitor-based therapy in pancreatic cancer

Pishvaian, M. J., Biankin, A. V., Bailey, P., Chang, D. K., Laheru, D., Wolfgang, C. L. & Brody, J. R. Apr 11 2017 In : British Journal of Cancer. 116, 8, p. 1021-1026 6 p.

Research output: Research - peer-reviewArticle

Platinum
Pancreatic Neoplasms
Mutation
Therapeutics
Poly(ADP-ribose) Polymerase Inhibitors
Neuroendocrine Tumors
Names
Immunohistochemistry
Recurrence

Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer

Shrestha, B. , Sun, Y. , Faisal, F. , Kim, V. , Soares, K. , Blair, A. , Herman, J. M. , Narang, A. , Dholakia, A. S. , Rosati, L. , Hacker-Prietz, A. , Chen, L. , Laheru, D. A. , De Jesus-Acosta, A. , Le, D. T. , Donehower, R. , Azad, N. , Diaz, L. A. , Murphy, A. , Lee, V. & 11 others Fishman, E. K., Hruban, R. H., Liang, T., Cameron, J. L., Makary, M., Weiss, M. J., Ahuja, N., He, J., Wolfgang, C. L., Huang, C. Y. & Zheng, L. Jul 1 2017 In : Cancer Medicine. 6, 7, p. 1552-1562 11 p.

Research output: Research - peer-reviewArticle

Pancreatic Neoplasms
Drug Therapy
Survival
Neoadjuvant Therapy
Adenocarcinoma

Metastatic pancreatic cancer: American society of clinical oncology clinical practice guideline summary

Sohal, D. P. S., Mangu, P. B. & Laheru, D. Apr 1 2017 In : Journal of Oncology Practice. 13, 4, p. 261-264 4 p.

Research output: Research - peer-reviewReview article